Literature DB >> 29579412

Urine biomarkers in the early stages of diseases: current status and perspective.

Jian Jing1, Youhe Gao1.   

Abstract

As a noninvasive and easily available biological fluid, the urine is becoming an important source for disease biomarker study. Change is essential for the usefulness of a biomarker. Without homeostasis mechanisms, urine can accommodate more changes, especially in the early stages of diseases. In this review, we summarize current status and discuss perspectives on the discovery of urine biomarkers in the early stages of diseases. We emphasize the advantages of urine biomarkers compared to plasma biomarkers for the diagnosis of diseases at early stages, propose a urine biomarker research roadmap, and highlight a novel membrane storage technique that enables large-scale urine sample collection and storage efficiently and economically. It is anticipated that urine biomarker studies will greatly promote early diagnosis, prevention, treatment, and prognosis of a variety of diseases, and provide strong support for translational and precision medicine.

Mesh:

Substances:

Year:  2018        PMID: 29579412

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  10 in total

1.  Bioinformatic analysis of dysregulated proteins in prostate cancer patients reveals putative urinary biomarkers and key biological pathways.

Authors:  Rui Vitorino; Margarida Fardilha; Tânia Lima; Rui Henrique
Journal:  Med Oncol       Date:  2021-01-16       Impact factor: 3.064

Review 2.  Role of biomarkers for early detection of ovarian cancer recurrence.

Authors:  Pierluigi Giampaolino; Virginia Foreste; Luigi Della Corte; Claudia Di Filippo; Giuseppe Iorio; Giuseppe Bifulco
Journal:  Gland Surg       Date:  2020-08

3.  Urinary biomarkers for the detection of ovarian cancer: a systematic review.

Authors:  Gemma L Owens; Chloe E Barr; Holly White; Kelechi Njoku; Emma J Crosbie
Journal:  Carcinogenesis       Date:  2022-05-19       Impact factor: 4.741

4.  Mechanism of Chronic Kidney Disease Progression and Novel Biomarkers: A Metabolomic Analysis of Experimental Glomerulonephritis.

Authors:  Kyoung Hee Han; Bora Kim; Sang Chun Ji; Hee Gyung Kang; Hae Il Cheong; Joo-Youn Cho; Il-Soo Ha
Journal:  Metabolites       Date:  2020-04-24

5.  Dynamic urinary proteomic analysis in a Walker 256 intracerebral tumor model.

Authors:  Linpei Zhang; Yuqiu Li; Wenshu Meng; Yanying Ni; Youhe Gao
Journal:  Cancer Med       Date:  2019-05-15       Impact factor: 4.452

6.  Study of risk factor of urinary calculi according to the association between stone composition with urine component.

Authors:  Pan Wang; Hongxian Zhang; Jiansuo Zhou; Shangjia Jin; Chong Liu; Boxin Yang; Liyan Cui
Journal:  Sci Rep       Date:  2021-04-22       Impact factor: 4.379

7.  Measuring Exercise-Induced Secreted Protein Acidic and Rich in Cysteine Expression as a Molecular Tool to Optimize Personalized Medicine.

Authors:  Abdelaziz Ghanemi; Mayumi Yoshioka; Jonny St-Amand
Journal:  Genes (Basel)       Date:  2021-11-20       Impact factor: 4.096

8.  A Novel Classifier Based on Urinary Proteomics for Distinguishing Between Benign and Malignant Ovarian Tumors.

Authors:  Maowei Ni; Jie Zhou; Zhihui Zhu; Jingtao Yuan; Wangang Gong; Jianqing Zhu; Zhiguo Zheng; Huajun Zhao
Journal:  Front Cell Dev Biol       Date:  2021-08-30

9.  Integrated Metabolomics and Proteomics Analysis of Urine in a Mouse Model of Posttraumatic Stress Disorder.

Authors:  Daxue Zhou; Chengyan Long; Yan Shao; Fei Li; Wei Sun; Zihan Zheng; Xiaoyang Wang; Yiwei Huang; Feng Pan; Gang Chen; Yanlei Guo; Yi Huang
Journal:  Front Neurosci       Date:  2022-03-11       Impact factor: 4.677

Review 10.  Urinary Biomarkers and Their Potential for the Non-Invasive Detection of Endometrial Cancer.

Authors:  Kelechi Njoku; Davide Chiasserini; Eleanor R Jones; Chloe E Barr; Helena O'Flynn; Anthony D Whetton; Emma J Crosbie
Journal:  Front Oncol       Date:  2020-11-03       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.